Integrated Diagnostics Holdings Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 7,137

Employees

  • Stock Symbol
  • IDHC

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $0.46
  • (As of Friday Closing)

Integrated Diagnostics Holdings General Information

Description

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Contact Information

Website
www.idhcorp.com
Formerly Known As
Al Mokhtabar, Al Borg Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • IFC 5
  • Saint Helier JE1 1ST
  • Jersey, United Kingdom
+44
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Stock Exchange
LON
Corporate Office
  • IFC 5
  • Saint Helier JE1 1ST
  • Jersey, United Kingdom
+44

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integrated Diagnostics Holdings Stock Performance

As of 20-Nov-2026, Integrated Diagnostics Holdings’s stock price is $0.46. Its current market cap is $269M with 581M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.46 $0.46 $0.45 - $0.83 $269M 581M 546K $0.05

Integrated Diagnostics Holdings Financials Summary

As of 30-Jun-2026, Integrated Diagnostics Holdings has a trailing 12-month revenue of $186M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 301,407 443,102 269,550 209,355
Revenue 185,959 159,446 126,169 134,362
EBITDA 64,466 54,180 42,976 39,355
Net Income 31,078 25,620 23,767 16,632
Total Assets 189,093 180,037 140,163 185,447
Total Debt 34,222 33,791 28,942 37,897
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Integrated Diagnostics Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Integrated Diagnostics Holdings‘s full profile, request access.

Request a free trial

Integrated Diagnostics Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integrated Diagnostics Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Integrated Diagnostics Holdings‘s full profile, request access.

Request a free trial

Integrated Diagnostics Holdings Investments & Acquisitions (5)

Integrated Diagnostics Holdings’s most recent deal was a Merger/Acquisition with Biolab KSA for . The deal was made on 09-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biolab KSA 09-Dec-2024 Merger/Acquisition Laboratory Services (Healthcare)
Biolab KSA 01-Feb-2023 Joint Venture Laboratory Services (Healthcare)
Echolab (Nigeria) 01-Dec-2017 Buyout/LBO Laboratory Services (Healthcare)
Al Borg Laboratory 27-Aug-2012 Merger of Equals Laboratory Services (Healthcare)
Al Mokhtabar 27-Aug-2012 Merger of Equals Laboratory Services (Healthcare)
To view Integrated Diagnostics Holdings’s complete investments and acquisitions history, request access »

Integrated Diagnostics Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view Integrated Diagnostics Holdings’s complete esg history, request access »

Integrated Diagnostics Holdings Exits (1)

Integrated Diagnostics Holdings’s most recent exit was on 01-Dec-2017 from Echolab (Nigeria). The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Echolab (Nigeria) 01-Dec-2017 Completed
  • 3 buyers
To view Integrated Diagnostics Holdings’s complete exits history, request access »

Integrated Diagnostics Holdings Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Al Borg Laboratory Cairo, Egypt 1991
Al Mokhtabar Giza, Egypt 1979
E.H. Hassell & Sons Trentham, United Kingdom 1974
Al Borg Scan

Integrated Diagnostics Holdings FAQs

  • When was Integrated Diagnostics Holdings founded?

    Integrated Diagnostics Holdings was founded in 2008.

  • Where is Integrated Diagnostics Holdings headquartered?

    Integrated Diagnostics Holdings is headquartered in Saint Helier, United Kingdom.

  • What is the size of Integrated Diagnostics Holdings?

    Integrated Diagnostics Holdings has 7,137 total employees.

  • What industry is Integrated Diagnostics Holdings in?

    Integrated Diagnostics Holdings’s primary industry is Laboratory Services (Healthcare).

  • Is Integrated Diagnostics Holdings a private or public company?

    Integrated Diagnostics Holdings is a Public company.

  • What is Integrated Diagnostics Holdings’s stock symbol?

    The ticker symbol for Integrated Diagnostics Holdings is IDHC.

  • What is the current stock price of Integrated Diagnostics Holdings?

    As of 20-Nov-2026 the stock price of Integrated Diagnostics Holdings is $0.46.

  • What is the current market cap of Integrated Diagnostics Holdings?

    The current market capitalization of Integrated Diagnostics Holdings is $269M.

  • What is Integrated Diagnostics Holdings’s current revenue?

    The trailing twelve month revenue for Integrated Diagnostics Holdings is $186M.

  • What is Integrated Diagnostics Holdings’s annual earnings per share (EPS)?

    Integrated Diagnostics Holdings’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process